• 1. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 2. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 3. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 4. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 5. An approach towards the synthesis of novel fused nitrogen tricyclic heterocyclic scaffolds via GBB reaction?
  Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Halopyrimidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Halopyrimidines

Professional Introduction to N'4'-sec-Butyl-6-chloro-pyrimidine-4,5-diamine (CAS No. 195252-58-5)

N'4'-sec-Butyl-6-chloro-pyrimidine-4,5-diamine is a significant compound in the field of pharmaceutical chemistry, characterized by its unique structural and functional properties. This compound, identified by the CAS number 195252-58-5, has garnered attention due to its potential applications in the development of novel therapeutic agents. The molecular structure of this pyrimidine derivative incorporates both a sec-butyl group and a chloro substituent, which contribute to its distinct chemical behavior and reactivity.

The importance of N'4'-sec-Butyl-6-chloro-pyrimidine-4,5-diamine lies in its utility as a key intermediate in synthetic chemistry. Its chemical formula and structural configuration make it a valuable building block for the synthesis of more complex molecules. In recent years, there has been growing interest in exploring the pharmacological properties of pyrimidine-based compounds, particularly those that exhibit antimicrobial and anti-inflammatory effects. The presence of both amino and chloro functional groups in N'4'-sec-Butyl-6-chloro-pyrimidine-4,5-diamine allows for diverse chemical modifications, enabling researchers to tailor its properties for specific applications.

Recent advancements in medicinal chemistry have highlighted the role of pyrimidine derivatives in addressing various therapeutic challenges. Studies have demonstrated that compounds with similar structural motifs can interact with biological targets in novel ways, leading to the discovery of new drug candidates. The sec-butyl group in N'4'-sec-Butyl-6-chloro-pyrimidine-4,5-diamine is particularly noteworthy, as it can influence the compound's solubility and metabolic stability. These factors are critical for optimizing drug delivery systems and ensuring therapeutic efficacy.

The chloro substituent on the pyrimidine ring adds another layer of complexity to the compound's behavior. Chlorinated pyrimidines are known to exhibit enhanced binding affinity to certain biological receptors, making them attractive candidates for drug development. Research has shown that such modifications can improve the potency and selectivity of pharmacological agents. In particular, N'4'-sec-Butyl-6-chloro-pyrimidine-4,5-diamine has been investigated for its potential role in inhibiting enzymes involved in cancer cell proliferation.

In the context of current research, N'4'-sec-Butyl-6-chloro-pyrimidine-4,5-diamine is being explored as a precursor for developing targeted therapies. The diamine functionality provides multiple sites for chemical modification, allowing researchers to design molecules with specific biological activities. For instance, studies have focused on incorporating this compound into nucleoside analogs that can selectively inhibit viral replication. The sec-butyl group's steric hindrance can also be leveraged to optimize drug interactions with cellular targets.

The synthesis of N'4'-sec-Butyl-6-chloro-pyrimidine-4,5-diamine involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic methodologies have been employed to enhance yield and purity, ensuring that the final product meets pharmaceutical standards. Techniques such as palladium-catalyzed cross-coupling reactions have been particularly useful in constructing the pyrimidine core structure efficiently.

From a computational chemistry perspective, molecular modeling studies have provided valuable insights into the interactions between N'4'-sec-Butyl-6-chloro-pyrimidine-4,5-diamine and biological targets. These simulations have helped researchers predict binding affinities and identify potential lead compounds for further optimization. The integration of experimental data with computational approaches has accelerated the drug discovery process significantly.

The pharmacokinetic properties of N'4'-sec-Butyl-6-chloro-pyrimidine-4,5-diamine are also under investigation to ensure its suitability for clinical applications. Factors such as absorption, distribution, metabolism, and excretion (ADME) are critical considerations when evaluating a compound's potential as a drug candidate. Preliminary studies suggest that this compound exhibits favorable pharmacokinetic profiles, which could enhance its therapeutic value.

In conclusion, N'4'-sec-Butyl-6-chloro-pyrimidine-4,5-diamine (CAS No. 195252-58-5) represents a promising compound in pharmaceutical research due to its unique structural features and potential applications. Ongoing studies continue to uncover new insights into its chemical behavior and biological activity, paving the way for innovative therapeutic strategies. As research progresses, this compound is expected to play a significant role in the development of next-generation pharmaceutical agents.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)